Min Jie Tang
Director of Finance/CFO chez SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Fortune : 721 772 $ au 31/03/2024
Profil
Min Jie Tang is currently the Chief Financial Officer & Executive Director at Shanghai Haohai Biological Technology Co., Ltd., the Director at Shenzhen New Industries Material of Ophthalmology Co., Ltd., and the Director at Shanghai Hengtai Vision Technology Co., Ltd.
Prior to his current roles, he obtained an undergraduate degree from Shanghai University in 1998.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
26/03/2024 | 48 835 ( 0,04% ) | 665 553 $ | 31/03/2024 | |
19/03/2024 | 11 000 ( 0,04% ) | 56 220 $ | 31/03/2024 |
Postes actifs de Min Jie Tang
Sociétés | Poste | Début |
---|---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Director of Finance/CFO | 09/12/2016 |
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Director/Board Member | 01/11/2016 |
Shanghai Hengtai Vision Technology Co., Ltd.
Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The private company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Director/Board Member | - |
Formation de Min Jie Tang
Shanghai University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Distribution Services |
Entreprise privées | 2 |
---|---|
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Health Technology |
Shanghai Hengtai Vision Technology Co., Ltd.
Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The private company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Health Services |